Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Techderm is a China-based medical aesthetics and healthcare manufacturer focused on hyaluronic acid gel products, especially injectable dermal fillers marketed under the Sofiderm brand. The company appears to operate from Hangzhou, Zhejiang, and manufactures cross-linked sodium hyaluronate products for plastic surgery, skin rejuvenation, ophthalmic and related aesthetic applications. Publicly available sources describe GMP-standard manufacturing capabilities and quality systems including ISO 9001, ISO 13485, CE-marked production controls, and MDSAP references. Its commercial portfolio includes HA dermal fillers, meso fillers, mesotherapy solutions, and related anti-aging and hair-focused products sold internationally. The company looks more like a commercial medical aesthetics manufacturer than a therapeutic drug developer, with limited evidence of a traditional biopharma clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Techderm.